Figure 2 Exosome composition

Slides:

Advertisements

Similar presentations

Figure 4 PET imaging in experimental pancreatic cancer

Advertisements

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Nephrol. doi: /nrneph

Figure 5 Dendritic cells in liver inflammation

Figure 1 Contribution of the gut microbiota

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 7 Treatment algorithm for perianal fistulizing disease

Figure 6 Injection of mesenchymal stem cells in perianal fistulas

Figure 1 Gut microorganisms at the intersection of several diseases

Figure 5 Lipid droplet consumption

Figure 1 Suppression of SLC22A3 and A-to-I editing

Figure 3 Life cycle of hepatitis E virus

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 The microbiome–gut–brain axis

Figure 7 Clinical options for HCC therapy

Figure 3 The T-cell cytokine tree in IBD

Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Figure 5 Exosomes for delivery of RNA interference therapeutics

Figure 1 Towards precision PRRT for neuroendocrine tumours

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Biosimilar development process

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 The 'leaky gut' hypothesis

Figure 4 Giant lipid droplet formation

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 HCV life cycle and site of action of DAAs

Figure 6 Combination therapy for HCC

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Figure 1 Definition and concept of ACLF

Figure 1 Functions, features and phenotypes of HSCs in normal and diseased livers Figure 1 | Functions, features and phenotypes of HSCs in normal and diseased.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Switching of biologic agents and biosimilars

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Gliomas—genetic landscape and biomarkers

Figure 1 Exosomes with siRNAs targeting

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

to the liver and promote patient-derived xenograft tumour growth

Figure 1 Environmental factors contributing to IBD pathogenesis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Figure 4 Diverse molecular mechanisms of long non-coding RNAs

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 The role of CTLA4 and PD1 in T cell activation

Figure 6 Possible therapeutic targets to decrease hepatic steatosis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Strategies to improve liver regeneration

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 New therapeutic approaches in IBD with their specific targets

Figure 5 Systems biological model of IBS

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Core molecular clock machinery

Figure 4 Role of exosomes in the pathogenesis of alcoholic hepatitis

Figure 1 Mechanistic classification of lncRNAs

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 New therapeutic approaches in IBD therapy based on blockade of T-cell homing and retention Figure 1 | New therapeutic approaches in IBD therapy.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Lifelong influences on the gut microbiome from

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Autophagosome formation in mammalian cells

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 4 Molecular signalling and immunological

Figure 1 The spread of colorectal cancer metastases

Presentation transcript:

Figure 2 Exosome composition Figure 2 | Exosome composition. Schematic representation of exosomes and examples of their molecular cargos. AGO2, Argonaute 2; ALIX, ALG-2-interacting protein X (also known as programmed cell death 6-interacting protein); GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HSP90, heat shock protein 90; lncRNA, long noncoding RNA; MHC, major histocompatibility complex class; RABs, Ras-related proteins; TSG101, tumour susceptibility gene 101. Szabo, G. & Momen-Heravi, F. (2017) Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.71